Smart manufacturing for continuous downstream processing of monoclonal antibodies at the lab-scale
SLAS Technology · 2026-07 · 39 · 100441
DOI: 10.1016/j.slast.2026.100441 ↗Kurz gefasst
Fachartikel in der Zeitschrift SLAS Technology, 2026-07. Verfasst von Andreas W Rebmann und 5 weiteren Autor:innen. Beteiligte Einrichtung: Chemical and Biological Engineering, Rensselaer Polytechnic Institute, 110 8th St, Troy, 12180, NY, United States of America. Electronic address: and…. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Biotechnology. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: U.S. Department of Commerce, National Institute of Standards and Technology, National Institute for Innovation in Manufacturing Biopharmaceuticals.
Abstract (Originalsprache)
Continuous bioprocessing has shown promise for efficiently scaling production of monoclonal antibodies for biotherapeutic production. Integrating process analytical technologies at the lab-scale stage improves the reliability of results during development and the translation of the system during scale-up. Smart Manufacturing provides a framework for implementing process analytical technologies at all process scales by leveraging modern hardware, software, and techniques. Demonstration of scaling and retrofitting a legacy system into a smart manufacturing system for the continuous downstream processing of monoclonal antibodies at the lab-scale was achieved through modular and flexible controller hardware, Industrial Internet-of-Things architecture, interoperable OPC-UA servers, and cloud computing on the Smart Manufacturing Interoperability Platform. The system consisted of lab-scale equipment connected to a legacy control device with limited operation and I/O. A new system of hardware was implemented that interfaced with the legacy equipment while also providing scalability, reconfigurability, and controllability. Peristaltic pumps, weigh-scales, single-use pressure sensors, and optical sensors were connected to edge devices which bridged the hardware and software used for process monitoring and control. Lab-scale implementation and operation challenges such as connecting multiple vendor systems and inconsistent pump flowrates were addressed. Water-based pump flowrate control tests were performed on the legacy equipment with readiness for deployment onto the smart manufacturing system. The techniques used include a Kalman Filter, steady-state data reconciliation, and closed-loop control based on scale measurements.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chemical and Biological Engineering, Rensselaer Polytechnic Institute, 110 8th St, Troy, 12180, NY, United States of America. Electronic address: andreasreb@gmail.com.
- Chemical and Biological Engineering, Rensselaer Polytechnic Institute, 110 8th St, Troy, 12180, NY, United States of America.
Förderung
- U.S. Department of Commerce
- National Institute of Standards and Technology
- National Institute for Innovation in Manufacturing Biopharmaceuticals
Zitieren
APA
Rebmann, A. W., Okpanum, J., Ghosh, S., Mergy, M., Przybycien, T. M., & Bequette, B. W. (2026). Smart manufacturing for continuous downstream processing of monoclonal antibodies at the lab-scale. SLAS Technology, 39, 100441. https://doi.org/10.1016/j.slast.2026.100441
Vancouver
Rebmann AW, Okpanum J, Ghosh S, Mergy M, Przybycien TM, Bequette BW. Smart manufacturing for continuous downstream processing of monoclonal antibodies at the lab-scale. SLAS Technology. 2026;39:100441. doi:10.1016/j.slast.2026.100441
BibTeX
@article{Rebmann2026,
author = {Rebmann, Andreas W and Okpanum, Jacinta and Ghosh, Sambit and Mergy, Matthew and Przybycien, Todd M and Bequette, B Wayne},
title = {Smart manufacturing for continuous downstream processing of monoclonal antibodies at the lab-scale},
journal = {SLAS Technology},
year = {2026},
volume = {39},
pages = {100441},
doi = {10.1016/j.slast.2026.100441}
}
EUVIMED